Kuros Biosciences AG Announces Launch of MagnetOs MIS Delivery System

Schlieren, Switzerland, August 5, 2025 — Kuros Biosciences AG, a Swiss biotechnology company specializing in orthobiologics, has successfully completed the first U.S. cases using its newly launched MagnetOs™ MIS Delivery System. This sterile, prefilled, single-use delivery system is engineered for minimally invasive spine procedures and has recently received FDA 510(k) clearance.

The completion of these initial cases marks a significant milestone for Kuros Biosciences, expanding surgeon access to innovative biologic technologies. The MagnetOs MIS Delivery System is designed to enhance the precision and safety of spine surgeries, aligning with Kuros’ mission to develop products for tissue repair and regeneration.

In addition to its U.S. market entry, Kuros Biosciences continues its global expansion efforts with incremental clearance in Brazil. This strategic move underscores the company’s commitment to broadening its international presence and making its advanced medical solutions available to a wider audience.

Kuros Biosciences AG, headquartered in Schlieren, Switzerland, operates in both the United States and Europe. The company is listed on the SIX Swiss Exchange and focuses on filling bony defects and stimulating bone formation at injury sites within the human skeletal system. For more information about Kuros Biosciences and its product offerings, visit their website at www.kuros.ch .

Company Overview

  • Sector: Health Care
  • Industry: Biotechnology
  • Primary Exchange: SIX Swiss Exchange
  • Currency: CHF
  • Close Price (2025-08-03): 27.68 CHF
  • 52 Weeks High: 32 CHF (2024-11-13)
  • 52 Weeks Low: 11.06 CHF (2024-08-07)
  • Market Cap: 1.15 billion CHF
  • Price Earnings Ratio: -261.42

Despite the recent advancements and market expansions, Kuros Biosciences faces financial challenges, as indicated by its negative price-earnings ratio. However, the successful launch of the MagnetOs MIS Delivery System and ongoing global expansion efforts may contribute positively to the company’s future growth and market valuation.